Journal
JOURNAL OF CELL BIOLOGY
Volume 191, Issue 4, Pages 783-794Publisher
ROCKEFELLER UNIV PRESS
DOI: 10.1083/jcb.201004033
Keywords
-
Categories
Funding
- Japan Society for the Promotion of Science
- Department of Molecular Biosciences at the University of Kansas
- National Institutes of Health/National Center for Research Resources Center For Cancer Experimental Therapeutics at the Centers of Biomedical Research Excellence (CCET-COBRE) [P20 RR015563]
- National Institutes of Health/National Institute of General Medical Sciences [3M80278, GM67945]
Ask authors/readers for more resources
DNA topoisomerase II alpha (TopoII alpha) is an essential chromosome associated enzyme with activity implicated in the resolution of tangled DNA at centromeres before anaphase onset However, the regulatory mechanism of TopoII alpha activity is not understood Here, we show that PIASy mediated small ubiquitin like modifier 2/3 (SUMO2/3) modification of TopoII alpha strongly inhibits TopoII alpha decatenation activity Using mass spectrometry and biochemical analysis, we demonstrate that TopoII alpha is SUMOylated at lysine 660 (Lys660), a residue located in the DNA gate domain, where both DNA cleavage and religation take place Remarkably, loss of SUMOylation on Lys660 eliminates SUMOylation dependent inhibition of TopoII alpha, which indicates that Lys660 SUMOylation is critical for PIASy mediated inhibition of TopoII alpha activity Together, our findings provide evidence for the regulation of TopoII alpha activity on mitotic chromosomes by SUMOylation Therefore, we propose a novel mechanism for regulation of centromeric DNA catenation during mitosis by PIASy mediated SUMOylation of TopoII alpha
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available